A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).

Source:http://linkedlifedata.com/resource/pubmed/id/19132191

Download in:

View as

General Info

PMID
19132191